About Smooth Drug Development, Next Generation E-CRO in Europe and Asia
Smooth Drug Development, Next Generation E-CRO in Europe and Asia is a Pharmaceuticals company, headquartered in Wilmington, with 51 - 200 employees and annual revenue of $50M - $100M.
Smooth Drug Development offers a full range of clinical trial, drug registration and post-marketing services, including consulting, development of registration strategy, conduct of clinical studies and pharmacovigilance in Europe and Asia. We cover wide geography: -EAEA Region -Europe -Latvia -Lithu...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Smooth Drug Development, Next Generation E-CRO in Europe and Asia Company Highlights
Phone Number
(812) 913-xxxx
Corporate Office Address
2711 Centerville Road
Wilmington, 19808
Website
Smooth Drug Development, Next Generation E-CRO in Europe and Asia Email Format
The most common Smooth Drug Development, Next Generation E-CRO in Europe and Asia email format is [f][last] (ex. jdoe@smoothdd.com), currently being used by 61% of Smooth Drug Development, Next Generation E-CRO in Europe and Asia business email addresses. There are 4 email formats used by Smooth Drug Development, Next Generation E-CRO in Europe and Asia.
Smooth Drug Development, Next Generation E-CRO in Europe and Asia Org
Smooth Drug Development, Next Generation E-CRO in Europe and Asia has 1 C-Level, 7 Director, 3 Manager, 1 Senior, 12 Mid-Level, and 2 Other employees.
Smooth Drug Development, Next Generation E-CRO in Europe and Asia Decision Makers
- CEODmitry Morozovsky
Smooth Drug Development, Next Generation E-CRO in Europe and Asia's Tech Stack
Frequently Asked Questions About
Smooth Drug Development, Next Generation E-CRO in Europe and Asia
Log in or sign up to get full contact details and additional support.
Who is the CEO of Smooth Drug Development, Next Generation E-CRO in Europe and Asia?
The CEO of Smooth Drug Development, Next Generation E-CRO in Europe and Asia is Dmitry Morozovsky. See full contact details ›
How many senior employees does Smooth Drug Development, Next Generation E-CRO in Europe and Asia have?
Smooth Drug Development, Next Generation E-CRO in Europe and Asia has 12 senior employees that are typically used for decision making.
What email format does Smooth Drug Development, Next Generation E-CRO in Europe and Asia use?
The most common Smooth Drug Development, Next Generation E-CRO in Europe and Asia email format is {f}{last} (e.g. jdoe@smoothdd.com).
Who are the key decision makers at Smooth Drug Development, Next Generation E-CRO in Europe and Asia?
Key decision makers at Smooth Drug Development, Next Generation E-CRO in Europe and Asia include Dmitry Morozovsky (CEO). See full contact details ›
What technologies does Smooth Drug Development, Next Generation E-CRO in Europe and Asia use?
Smooth Drug Development, Next Generation E-CRO in Europe and Asia uses technologies including CentOS, Cloudflare, and Google Maps.
How do I contact Smooth Drug Development, Next Generation E-CRO in Europe and Asia?
To contact Smooth Drug Development, Next Generation E-CRO in Europe and Asia, visit smoothdd.com.
What companies are similar to Smooth Drug Development, Next Generation E-CRO in Europe and Asia?
Companies similar to Smooth Drug Development, Next Generation E-CRO in Europe and Asia include American Family Insurance, The Standard, and Guy Carpenter.
Where is Smooth Drug Development, Next Generation E-CRO in Europe and Asia headquartered?
Smooth Drug Development, Next Generation E-CRO in Europe and Asia is headquartered at 2711 Centerville Road, Wilmington.
What is the main phone number for Smooth Drug Development, Next Generation E-CRO in Europe and Asia?
The main phone number for Smooth Drug Development, Next Generation E-CRO in Europe and Asia is (812) 913-xxxx.
What is the official website for Smooth Drug Development, Next Generation E-CRO in Europe and Asia?
The official website for Smooth Drug Development, Next Generation E-CRO in Europe and Asia is smoothdd.com.
What is the annual revenue of Smooth Drug Development, Next Generation E-CRO in Europe and Asia?
The annual revenue of Smooth Drug Development, Next Generation E-CRO in Europe and Asia is $50M - $100M.
How many employees does Smooth Drug Development, Next Generation E-CRO in Europe and Asia have?
Smooth Drug Development, Next Generation E-CRO in Europe and Asia has 51 - 200 employees.
What industry is Smooth Drug Development, Next Generation E-CRO in Europe and Asia in?
Smooth Drug Development, Next Generation E-CRO in Europe and Asia is in the Pharmaceuticals industry.
Last updated: November 4, 2025